Novel Therapeutic Strategies in Myeloma – Module 4

CME: .5

March 3, 2022
/ Print / Reprints /
| Share More
/ Text Size+

Target Audience

This activity is designed to meet the educational needs of hematologists, oncologists, and other healthcare professionals involved in the diagnosis and treatment of patients with blood cancers.

Program Overview

This activity provides an overview of recent therapeutic advances for patients with newly diagnosed or relapsed multiple myeloma and the mechanisms by which novel therapies work.

Learning Objective

Upon completion of this activity, participants should be better able to:

  • Assess how novel therapeutic strategies lead to improved survival in myeloma

Post a comment to this article